—Sharon Waisbrod, MD, discusses a systematic review and meta-analysis of prospective and retrospective studies published over an 11-year period that evaluated the prevalence of cancer in patients with ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
These differences remained significant beyond the initial 90 days, indicating durable diagnostic sensitivity and facilitating earlier, risk-appropriate treatment decisions, which supports broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results